Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boyitong Pharmaceutical Technology is a specialized Contract Research Organization (CRO) and biotechnology firm headquartered in the Suzhou Industrial Park (BioBay), China. The company focuses on early-stage drug discovery, providing expert services in medicinal chemistry, lead optimization, and the design and synthesis of complex chemical libraries. By leveraging its integrated drug design platforms, Boyitong assists global pharmaceutical and biotech partners in identifying and developing novel small molecule candidates for challenging therapeutic targets. The firm is recognized for its high-quality synthetic capabilities and its proficiency in accelerating the hit-to-lead and lead-optimization phases of drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boyitong Pharmaceutical Technology.